Test & Treat
Access to effective oral treatments for COVID-19, especially for high-risk populations and those without access to vaccination, can help save lives and limit the impact of future surges. But these therapies require access to accurate, rapid tests to be most valuable, and challenges remain on supply, demand, and financing for both tests and oral therapies. In our recent report, Pills to People, we lay out key recommendations to enable more equitable global access to oral therapies and support implementation of test-and-treat strategies.
More to Explore
The COVID GAP team is tracking key metrics on both testing and equitable access to oral therapeutics. Explore the pages below for data and further insights on each of these areas.
Read More About Test & Treat
Pills to People: Accelerating Equitable Global Access to Oral Therapeutics for COVID-19
March 3, 2022: While vaccines remain a critical aspect of global pandemic response, COVID GAP emphasizes in its new report, Pills to People: Accelerating Equitable Global Access to Oral Therapeutics for COVID-19, the vital need for a “vaccination plus” strategy that expands the COVID arsenal to include oral treatments.